Advertisement
Loading...

Phibro Animal Health Corporation

PAHCNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$34.37
$-1.78(-4.92%)
U.S. Market opens in 28h 26m

Phibro Animal Health Corporation (PAHC) Stock Overview

Explore Phibro Animal Health Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.4B
P/E Ratio14.57
EPS (TTM)$2.33
ROE0.29%
Fundamental Analysis

AI Price Forecasts

1 Month$56.79
3 Months$54.76
1 Year Target$62.69

PAHC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Phibro Animal Health Corporation (PAHC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 25.53, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $62.69.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.57 and a market capitalization of 1.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.92%
5-Day Change
-19.24%
1-Month Change
-37.52%
3-Month Change
-34.23%
6-Month Change
-23.79%
Year-to-Date (YTD) Change
-8.00%
1-Year Change
44.23%
3-Year Change
138.35%
5-Year Change
22.44%
All-Time (Max) Change
102.18%

Contact Information

201 329 7300
Glenpointe Centre East, Teaneck, NJ, 07666-6712

Company Facts

1,940 Employees
IPO DateApr 11, 2014
CountryUS
Actively Trading

Frequently Asked Questions